Mesalamine
NDC 68382-452, Mesalamine, capsule, extended release, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-452
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208954
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-452 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE.375 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-452-19 | 68382045219 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-452-19) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cd8493f7-91fd-4c2d-b3d7-c1301825586bNADAC price for package 68382045219
GET /v1/drugs/nadac/68382045219
Use it
Look up 68382-452 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-452 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-452. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.